About Zogenix
Zogenix is a company based in Emeryville (United States) founded in 2006 by Bret Megargel was acquired by UCB in January 2022.. Zogenix has raised $149.06 million across 7 funding rounds from investors including Blackstone, UCB and CIT. Zogenix has completed 2 acquisitions, including Brabant Pharma and Modis Therapeutics. Zogenix operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Heron Therapeutics, among others.
- Headquarter Emeryville, United States
- Founders Bret Megargel
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zogenix, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$149.06 M (USD)
in 7 rounds
-
Latest Funding Round
$251.3 M (USD), Post-IPO
Oct 04, 2017
-
Investors
Blackstone
& 9 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Brabant Pharma
& 1 more
-
Acquired by
UCB
(Jan 19, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Software Development Team
219 people
Leadership Team
92 people
Head Team
57 people
Global Team
39 people
Senior Team
36 people
Operations Team
36 people
Product Management Team
34 people
Human Resources and Administration
22 people
Unlock access to complete
Funding Insights of Zogenix
Zogenix has successfully raised a total of $149.06M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $251.3 million completed in October 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $251.3M
-
First Round
First Round
(28 Aug 2006)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2017 | Amount | Post-IPO - Zogenix | Valuation |
investors |
|
| Jun, 2011 | Amount | Post-IPO - Zogenix | Valuation |
investors |
|
| Jul, 2010 | Amount | Series B - Zogenix | Valuation | Domain Associates , Scale Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Zogenix
Zogenix has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Blackstone, UCB and CIT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare royalty investments are focused on US and UK markets.
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are focused on US companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zogenix
Zogenix has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Brabant Pharma and Modis Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapies for rare genetic mitochondrial diseases are developed.
|
2016 | ||||
|
Therapeutics for rare CNS diseases like Dravet Syndrome were developed.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Zogenix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zogenix Comparisons
Competitors of Zogenix
Zogenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Heron Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zogenix
Frequently Asked Questions about Zogenix
When was Zogenix founded?
Zogenix was founded in 2006.
Where is Zogenix located?
Zogenix is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Is Zogenix a funded company?
Zogenix is a funded company, having raised a total of $149.06M across 7 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Aug 28, 2006.
What does Zogenix do?
Zogenix was founded in 2006 as a specialty pharmaceutical company based in Emeryville, United States. Late-stage product candidates are advanced for treating central nervous system disorders and pain. The lead candidate, sumatriptan DosePro, facilitates needle-free subcutaneous administration of sumatriptan for acute migraine relief. ZX002, the second candidate, provides a controlled-release form of hydrocodone targeted at chronic pain management.
Who are the top competitors of Zogenix?
Zogenix's top competitors include Flexion Therapeutics, Cara Therapeutics and Trevena.
How many acquisitions has Zogenix made?
Zogenix has made 2 acquisitions, including Brabant Pharma, and Modis Therapeutics.
Who are Zogenix's investors?
Zogenix has 10 investors. Key investors include Blackstone, UCB, CIT, Oxford Finance, and HealthCare Royalty Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.